2 employees
Rewellio stroke is the most common neurological diagnosis.
2017
$909K
from 2 investors over 2 rounds
Rewellio GmbH raised $909K on March 19, 2019
Investors: FFG Österreichische Forschungsförderungsgesellschaft mbH
Rewellio GmbH raised undisclosed on June 1, 2018
Investors: tech2b Inkubator GmbH